Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Gene Therapy Drugs Market Growth (Status and Outlook) 2022-2028

  • LP 4814218
  • 101 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Gene Therapy Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Gene Therapy Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Gene Therapy Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Gene Therapy Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gene Therapy Drugs market, reaching US$ million by the year 2028. As for the Europe Gene Therapy Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Gene Therapy Drugs players cover F. Hoffmann-La Roche AG, Novartis International AG, Gilead Sciences, Inc., and Ultragenyx Pharmaceutical,Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy Drugs market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Neuromuscular Disease

Genetic Disease

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospital

Pharmacy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

F. Hoffmann-La Roche AG

Novartis International AG

Gilead Sciences, Inc.

Ultragenyx Pharmaceutical,Inc.

Applied Genetic Technologies Corp

Audentes Therapeutics

BioMarin Pharmaceutical

Bluebird Bio

Nightstar Therapeutics

Sangamo Therapeutics

Spark Therapeutics

uniQure

VBL Therapeutics

Voyager Therapeutics

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gene Therapy Drugs Market Size 2017-2028

2.1.2 Gene Therapy Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Gene Therapy Drugs Segment by Type

2.2.1 Neuromuscular Disease

2.2.2 Genetic Disease

2.2.3 Other

2.3 Gene Therapy Drugs Market Size by Type

2.3.1 Gene Therapy Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Gene Therapy Drugs Market Size Market Share by Type (2017-2022)

2.4 Gene Therapy Drugs Segment by Application

2.4.1 Hospital

2.4.2 Pharmacy

2.5 Gene Therapy Drugs Market Size by Application

2.5.1 Gene Therapy Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Gene Therapy Drugs Market Size Market Share by Application (2017-2022)

3 Gene Therapy Drugs Market Size by Player

3.1 Gene Therapy Drugs Market Size Market Share by Players

3.1.1 Global Gene Therapy Drugs Revenue by Players (2020-2022)

3.1.2 Global Gene Therapy Drugs Revenue Market Share by Players (2020-2022)

3.2 Global Gene Therapy Drugs Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Gene Therapy Drugs by Regions

4.1 Gene Therapy Drugs Market Size by Regions (2017-2022)

4.2 Americas Gene Therapy Drugs Market Size Growth (2017-2022)

4.3 APAC Gene Therapy Drugs Market Size Growth (2017-2022)

4.4 Europe Gene Therapy Drugs Market Size Growth (2017-2022)

4.5 Middle East & Africa Gene Therapy Drugs Market Size Growth (2017-2022)

5 Americas

5.1 Americas Gene Therapy Drugs Market Size by Country (2017-2022)

5.2 Americas Gene Therapy Drugs Market Size by Type (2017-2022)

5.3 Americas Gene Therapy Drugs Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gene Therapy Drugs Market Size by Region (2017-2022)

6.2 APAC Gene Therapy Drugs Market Size by Type (2017-2022)

6.3 APAC Gene Therapy Drugs Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Gene Therapy Drugs by Country (2017-2022)

7.2 Europe Gene Therapy Drugs Market Size by Type (2017-2022)

7.3 Europe Gene Therapy Drugs Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gene Therapy Drugs by Region (2017-2022)

8.2 Middle East & Africa Gene Therapy Drugs Market Size by Type (2017-2022)

8.3 Middle East & Africa Gene Therapy Drugs Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Gene Therapy Drugs Market Forecast

10.1 Global Gene Therapy Drugs Forecast by Regions (2023-2028)

10.1.1 Global Gene Therapy Drugs Forecast by Regions (2023-2028)

10.1.2 Americas Gene Therapy Drugs Forecast

10.1.3 APAC Gene Therapy Drugs Forecast

10.1.4 Europe Gene Therapy Drugs Forecast

10.1.5 Middle East & Africa Gene Therapy Drugs Forecast

10.2 Americas Gene Therapy Drugs Forecast by Country (2023-2028)

10.2.1 United States Gene Therapy Drugs Market Forecast

10.2.2 Canada Gene Therapy Drugs Market Forecast

10.2.3 Mexico Gene Therapy Drugs Market Forecast

10.2.4 Brazil Gene Therapy Drugs Market Forecast

10.3 APAC Gene Therapy Drugs Forecast by Region (2023-2028)

10.3.1 China Gene Therapy Drugs Market Forecast

10.3.2 Japan Gene Therapy Drugs Market Forecast

10.3.3 Korea Gene Therapy Drugs Market Forecast

10.3.4 Southeast Asia Gene Therapy Drugs Market Forecast

10.3.5 India Gene Therapy Drugs Market Forecast

10.3.6 Australia Gene Therapy Drugs Market Forecast

10.4 Europe Gene Therapy Drugs Forecast by Country (2023-2028)

10.4.1 Germany Gene Therapy Drugs Market Forecast

10.4.2 France Gene Therapy Drugs Market Forecast

10.4.3 UK Gene Therapy Drugs Market Forecast

10.4.4 Italy Gene Therapy Drugs Market Forecast

10.4.5 Russia Gene Therapy Drugs Market Forecast

10.5 Middle East & Africa Gene Therapy Drugs Forecast by Region (2023-2028)

10.5.1 Egypt Gene Therapy Drugs Market Forecast

10.5.2 South Africa Gene Therapy Drugs Market Forecast

10.5.3 Israel Gene Therapy Drugs Market Forecast

10.5.4 Turkey Gene Therapy Drugs Market Forecast

10.5.5 GCC Countries Gene Therapy Drugs Market Forecast

10.6 Global Gene Therapy Drugs Forecast by Type (2023-2028)

10.7 Global Gene Therapy Drugs Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 F. Hoffmann-La Roche AG

11.1.1 F. Hoffmann-La Roche AG Company Information

11.1.2 F. Hoffmann-La Roche AG Gene Therapy Drugs Product Offered

11.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 F. Hoffmann-La Roche AG Main Business Overview

11.1.5 F. Hoffmann-La Roche AG Latest Developments

11.2 Novartis International AG

11.2.1 Novartis International AG Company Information

11.2.2 Novartis International AG Gene Therapy Drugs Product Offered

11.2.3 Novartis International AG Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Novartis International AG Main Business Overview

11.2.5 Novartis International AG Latest Developments

11.3 Gilead Sciences, Inc.

11.3.1 Gilead Sciences, Inc. Company Information

11.3.2 Gilead Sciences, Inc. Gene Therapy Drugs Product Offered

11.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Gilead Sciences, Inc. Main Business Overview

11.3.5 Gilead Sciences, Inc. Latest Developments

11.4 Ultragenyx Pharmaceutical,Inc.

11.4.1 Ultragenyx Pharmaceutical,Inc. Company Information

11.4.2 Ultragenyx Pharmaceutical,Inc. Gene Therapy Drugs Product Offered

11.4.3 Ultragenyx Pharmaceutical,Inc. Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Ultragenyx Pharmaceutical,Inc. Main Business Overview

11.4.5 Ultragenyx Pharmaceutical,Inc. Latest Developments

11.5 Applied Genetic Technologies Corp

11.5.1 Applied Genetic Technologies Corp Company Information

11.5.2 Applied Genetic Technologies Corp Gene Therapy Drugs Product Offered

11.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Applied Genetic Technologies Corp Main Business Overview

11.5.5 Applied Genetic Technologies Corp Latest Developments

11.6 Audentes Therapeutics

11.6.1 Audentes Therapeutics Company Information

11.6.2 Audentes Therapeutics Gene Therapy Drugs Product Offered

11.6.3 Audentes Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Audentes Therapeutics Main Business Overview

11.6.5 Audentes Therapeutics Latest Developments

11.7 BioMarin Pharmaceutical

11.7.1 BioMarin Pharmaceutical Company Information

11.7.2 BioMarin Pharmaceutical Gene Therapy Drugs Product Offered

11.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 BioMarin Pharmaceutical Main Business Overview

11.7.5 BioMarin Pharmaceutical Latest Developments

11.8 Bluebird Bio

11.8.1 Bluebird Bio Company Information

11.8.2 Bluebird Bio Gene Therapy Drugs Product Offered

11.8.3 Bluebird Bio Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Bluebird Bio Main Business Overview

11.8.5 Bluebird Bio Latest Developments

11.9 Nightstar Therapeutics

11.9.1 Nightstar Therapeutics Company Information

11.9.2 Nightstar Therapeutics Gene Therapy Drugs Product Offered

11.9.3 Nightstar Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Nightstar Therapeutics Main Business Overview

11.9.5 Nightstar Therapeutics Latest Developments

11.10 Sangamo Therapeutics

11.10.1 Sangamo Therapeutics Company Information

11.10.2 Sangamo Therapeutics Gene Therapy Drugs Product Offered

11.10.3 Sangamo Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Sangamo Therapeutics Main Business Overview

11.10.5 Sangamo Therapeutics Latest Developments

11.11 Spark Therapeutics

11.11.1 Spark Therapeutics Company Information

11.11.2 Spark Therapeutics Gene Therapy Drugs Product Offered

11.11.3 Spark Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Spark Therapeutics Main Business Overview

11.11.5 Spark Therapeutics Latest Developments

11.12 uniQure

11.12.1 uniQure Company Information

11.12.2 uniQure Gene Therapy Drugs Product Offered

11.12.3 uniQure Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 uniQure Main Business Overview

11.12.5 uniQure Latest Developments

11.13 VBL Therapeutics

11.13.1 VBL Therapeutics Company Information

11.13.2 VBL Therapeutics Gene Therapy Drugs Product Offered

11.13.3 VBL Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 VBL Therapeutics Main Business Overview

11.13.5 VBL Therapeutics Latest Developments

11.14 Voyager Therapeutics

11.14.1 Voyager Therapeutics Company Information

11.14.2 Voyager Therapeutics Gene Therapy Drugs Product Offered

11.14.3 Voyager Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Voyager Therapeutics Main Business Overview

11.14.5 Voyager Therapeutics Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Gene Therapy Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Neuromuscular Disease

Table 3. Major Players of Genetic Disease

Table 4. Major Players of Other

Table 5. Gene Therapy Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global Gene Therapy Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global Gene Therapy Drugs Market Size Market Share by Type (2017-2022)

Table 8. Gene Therapy Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Gene Therapy Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global Gene Therapy Drugs Market Size Market Share by Application (2017-2022)

Table 11. Global Gene Therapy Drugs Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global Gene Therapy Drugs Revenue Market Share by Player (2020-2022)

Table 13. Gene Therapy Drugs Key Players Head office and Products Offered

Table 14. Gene Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Gene Therapy Drugs Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global Gene Therapy Drugs Market Size Market Share by Regions (2017-2022)

Table 19. Americas Gene Therapy Drugs Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas Gene Therapy Drugs Market Size Market Share by Country (2017-2022)

Table 21. Americas Gene Therapy Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas Gene Therapy Drugs Market Size Market Share by Type (2017-2022)

Table 23. Americas Gene Therapy Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas Gene Therapy Drugs Market Size Market Share by Application (2017-2022)

Table 25. APAC Gene Therapy Drugs Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC Gene Therapy Drugs Market Size Market Share by Region (2017-2022)

Table 27. APAC Gene Therapy Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC Gene Therapy Drugs Market Size Market Share by Type (2017-2022)

Table 29. APAC Gene Therapy Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC Gene Therapy Drugs Market Size Market Share by Application (2017-2022)

Table 31. Europe Gene Therapy Drugs Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe Gene Therapy Drugs Market Size Market Share by Country (2017-2022)

Table 33. Europe Gene Therapy Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe Gene Therapy Drugs Market Size Market Share by Type (2017-2022)

Table 35. Europe Gene Therapy Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe Gene Therapy Drugs Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa Gene Therapy Drugs Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa Gene Therapy Drugs Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa Gene Therapy Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Gene Therapy Drugs Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa Gene Therapy Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Gene Therapy Drugs Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of Gene Therapy Drugs

Table 44. Key Market Challenges & Risks of Gene Therapy Drugs

Table 45. Key Industry Trends of Gene Therapy Drugs

Table 46. Global Gene Therapy Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global Gene Therapy Drugs Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global Gene Therapy Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global Gene Therapy Drugs Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global Gene Therapy Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global Gene Therapy Drugs Market Size Market Share Forecast by Application (2023-2028)

Table 52. F. Hoffmann-La Roche AG Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors

Table 53. F. Hoffmann-La Roche AG Gene Therapy Drugs Product Offered

Table 54. F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. F. Hoffmann-La Roche AG Main Business

Table 56. F. Hoffmann-La Roche AG Latest Developments

Table 57. Novartis International AG Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors

Table 58. Novartis International AG Gene Therapy Drugs Product Offered

Table 59. Novartis International AG Main Business

Table 60. Novartis International AG Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Novartis International AG Latest Developments

Table 62. Gilead Sciences, Inc. Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors

Table 63. Gilead Sciences, Inc. Gene Therapy Drugs Product Offered

Table 64. Gilead Sciences, Inc. Main Business

Table 65. Gilead Sciences, Inc. Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Gilead Sciences, Inc. Latest Developments

Table 67. Ultragenyx Pharmaceutical,Inc. Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors

Table 68. Ultragenyx Pharmaceutical,Inc. Gene Therapy Drugs Product Offered

Table 69. Ultragenyx Pharmaceutical,Inc. Main Business

Table 70. Ultragenyx Pharmaceutical,Inc. Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Ultragenyx Pharmaceutical,Inc. Latest Developments

Table 72. Applied Genetic Technologies Corp Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors

Table 73. Applied Genetic Technologies Corp Gene Therapy Drugs Product Offered

Table 74. Applied Genetic Technologies Corp Main Business

Table 75. Applied Genetic Technologies Corp Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Applied Genetic Technologies Corp Latest Developments

Table 77. Audentes Therapeutics Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors

Table 78. Audentes Therapeutics Gene Therapy Drugs Product Offered

Table 79. Audentes Therapeutics Main Business

Table 80. Audentes Therapeutics Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Audentes Therapeutics Latest Developments

Table 82. BioMarin Pharmaceutical Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors

Table 83. BioMarin Pharmaceutical Gene Therapy Drugs Product Offered

Table 84. BioMarin Pharmaceutical Main Business

Table 85. BioMarin Pharmaceutical Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. BioMarin Pharmaceutical Latest Developments

Table 87. Bluebird Bio Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors

Table 88. Bluebird Bio Gene Therapy Drugs Product Offered

Table 89. Bluebird Bio Main Business

Table 90. Bluebird Bio Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Bluebird Bio Latest Developments

Table 92. Nightstar Therapeutics Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors

Table 93. Nightstar Therapeutics Gene Therapy Drugs Product Offered

Table 94. Nightstar Therapeutics Main Business

Table 95. Nightstar Therapeutics Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Nightstar Therapeutics Latest Developments

Table 97. Sangamo Therapeutics Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors

Table 98. Sangamo Therapeutics Gene Therapy Drugs Product Offered

Table 99. Sangamo Therapeutics Main Business

Table 100. Sangamo Therapeutics Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Sangamo Therapeutics Latest Developments

Table 102. Spark Therapeutics Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors

Table 103. Spark Therapeutics Gene Therapy Drugs Product Offered

Table 104. Spark Therapeutics Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Spark Therapeutics Main Business

Table 106. Spark Therapeutics Latest Developments

Table 107. uniQure Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors

Table 108. uniQure Gene Therapy Drugs Product Offered

Table 109. uniQure Main Business

Table 110. uniQure Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 111. uniQure Latest Developments

Table 112. VBL Therapeutics Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors

Table 113. VBL Therapeutics Gene Therapy Drugs Product Offered

Table 114. VBL Therapeutics Main Business

Table 115. VBL Therapeutics Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. VBL Therapeutics Latest Developments

Table 117. Voyager Therapeutics Details, Company Type, Gene Therapy Drugs Area Served and Its Competitors

Table 118. Voyager Therapeutics Gene Therapy Drugs Product Offered

Table 119. Voyager Therapeutics Main Business

Table 120. Voyager Therapeutics Gene Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 121. Voyager Therapeutics Latest Developments

List of Figures

Figure 1. Gene Therapy Drugs Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Gene Therapy Drugs Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Gene Therapy Drugs Market Size Market Share by Type in 2021

Figure 7. Gene Therapy Drugs in Hospital

Figure 8. Global Gene Therapy Drugs Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Gene Therapy Drugs in Pharmacy

Figure 10. Global Gene Therapy Drugs Market: Pharmacy (2017-2022) & ($ Millions)

Figure 11. Global Gene Therapy Drugs Market Size Market Share by Application in 2021

Figure 12. Global Gene Therapy Drugs Revenue Market Share by Player in 2021

Figure 13. Global Gene Therapy Drugs Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Gene Therapy Drugs Market Size 2017-2022 ($ Millions)

Figure 15. APAC Gene Therapy Drugs Market Size 2017-2022 ($ Millions)

Figure 16. Europe Gene Therapy Drugs Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Gene Therapy Drugs Market Size 2017-2022 ($ Millions)

Figure 18. Americas Gene Therapy Drugs Value Market Share by Country in 2021

Figure 19. Americas Gene Therapy Drugs Consumption Market Share by Type in 2021

Figure 20. Americas Gene Therapy Drugs Market Size Market Share by Application in 2021

Figure 21. United States Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Gene Therapy Drugs Market Size Market Share by Region in 2021

Figure 26. APAC Gene Therapy Drugs Market Size Market Share by Application in 2021

Figure 27. China Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Gene Therapy Drugs Market Size Market Share by Country in 2021

Figure 34. Europe Gene Therapy Drugs Market Size Market Share by Type in 2021

Figure 35. Europe Gene Therapy Drugs Market Size Market Share by Application in 2021

Figure 36. Germany Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Gene Therapy Drugs Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Gene Therapy Drugs Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Gene Therapy Drugs Market Size Market Share by Application in 2021

Figure 44. Egypt Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Gene Therapy Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 50. APAC Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 51. Europe Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 53. United States Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 54. Canada Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 57. China Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 58. Japan Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 59. Korea Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 61. India Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 62. Australia Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 63. Germany Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 64. France Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 65. UK Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 66. Italy Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 67. Russia Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 68. Spain Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 71. Israel Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Gene Therapy Drugs Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390